LivingGLP1
Study S002649

Research of Intensive Lifestyle Intervention for Overweight PCOS Patients With Impaired Glucose Tolerance in Their Metabolic and Reproductive Abnormalities Treatment

Registration

Registration
NCT02446834
Study type
INTERVENTIONAL
Allocation
RANDOMIZED
Masking
NONE
Status
COMPLETED
Enrollment
40
Start
2015-04
Primary completion
2017-12
Lead sponsor
RenJi Hospital
Conditions
Polycystic Ovary Syndrome
Interventions
BEHAVIORAL:intensive lifestyle intervention; DRUG:GLP-1 Receptor Agonists; DRUG:Metformin; DRUG:Acarbose
Results posted
FALSE
Individual participant data sharing
UNDECIDED

Registered primary outcomes

  • changes of Islet β-cell functions from baseline [up to 12 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.